Why Ascendis Pharma Stock Is Plunging Today
A regulatory hiccup is weighing on the biopharma’s shares today.
Mindfully Curated
A regulatory hiccup is weighing on the biopharma’s shares today.
A regulatory hiccup is weighing on the biopharma’s shares today.
The company reported vehicle production figures, and investors are reaching for a yellow flag.
The company reported vehicle production figures, and investors are reaching for a yellow flag.
Shares of the AI stock have tripled this year, but it could be due for a breather.
Shares of the AI stock have tripled this year, but it could be due for a breather.
A buyout agreement is elevating the pet diagnostics company’s shares today.
A buyout agreement is elevating the pet diagnostics company’s shares today.
IBM continues to innovate in chip design and packaging, and with recent government support, it’s poised for even greater success.
IBM continues to innovate in chip design and packaging, and with recent government support, it’s poised for even greater success.
Tesla continues to break records, but its 2023 first-quarter vehicle delivery results weren’t entirely positive.
Tesla continues to break records, but its 2023 first-quarter vehicle delivery results weren’t entirely positive.
Is it time to buy oil stocks again?
Is it time to buy oil stocks again?
Some unlikely stocks are soaring this year.
Some unlikely stocks are soaring this year.
One important area of progress might be overlooked.
One important area of progress might be overlooked.
There’s no stopping this big tech giant.
There’s no stopping this big tech giant.